News Conference News EAS 2019 Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role Michael O'Riordan June 07, 2019
News Conference News EAS 2019 Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality Michael O'Riordan June 05, 2019
News Conference News EAS 2019 Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION Michael O'Riordan June 04, 2019
News Conference News EAS 2019 FH Patients Derive Biggest Absolute Benefit From Statin Therapy: 4S Analysis Michael O'Riordan June 03, 2019
News Conference News EAS 2019 Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients Michael O'Riordan May 30, 2019
News Conference News EAS 2019 CHD Mortality Significantly Elevated in Patients With Severe FH Michael O'Riordan May 29, 2019
News Conference News EAS 2019 Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis Michael O'Riordan May 28, 2019
News Daily News Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention Michael O'Riordan May 20, 2019
News Daily News Familial Hypercholesterolemia Seen in 10% of Young MI Patients Michael O'Riordan May 15, 2019
News Daily News Bariatric Surgery Linked to Survival Advantage After MI and CVA Michael O'Riordan May 13, 2019
News Daily News FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors Michael O'Riordan May 08, 2019
News Daily News Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure Michael O'Riordan May 06, 2019
News Daily News Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy Michael O'Riordan May 06, 2019
News Daily News Mortality From Heart Failure Increasing in United States Michael O'Riordan May 06, 2019
News Daily News Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD Michael O'Riordan May 02, 2019
News Daily News Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow Michael O'Riordan April 30, 2019
News Daily News PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction Michael O'Riordan April 29, 2019
News Daily News Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study Michael O'Riordan April 24, 2019
News Daily News Patients Stop CVD Medications When Their Pharmacy Closes Michael O'Riordan April 19, 2019
News Daily News Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events Michael O'Riordan April 18, 2019